⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RARE News
Ultragenyx Pharmaceutical Inc.
RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit
prnewswire.com
RARE
Pomerantz LLP Alerts Shareholders to Investor Suit Involving Ultragenyx Pharmaceutical Inc. – RARE
accessnewswire.com
RARE
Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
accessnewswire.com
RARE
Kessler Topaz Meltzer & Check, LLP - Class Action Announcement for Ultragenyx Pharmaceutical Inc. Investors: A Securities Fraud Class Action Lawsuit Was Filed Against Ultragenyx Pharmaceutical Inc.
globenewswire.com
RARE
RARE INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Ultragenyx Pharmaceutical (RARE) Investors of Securities Class Action Deadline on April 6, 2026 Ready to Announce with Confidence?
newsfilecorp.com
RARE
PLUG
Pomerantz LLP Advises Shareholders of Class Action Filing Involving Ultragenyx Pharmaceutical Inc. – RARE
accessnewswire.com
RARE
RARE SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ultragenyx Pharmaceutical Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
RARE
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Ultragenyx Pharmaceutical Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RARE
globenewswire.com
RARE
Pomerantz LLP Alerts Shareholders to Investor Suit Filed Against Ultragenyx Pharmaceutical Inc. – RARE
accessnewswire.com
RARE
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Ultragenyx Pharmaceutical Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RARE
accessnewswire.com
RARE